Angina Pectoris: Clinical Trials

1 trial for Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Enrolling by invitation 1
Phase 31Enrolling by invitation 1

Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm
Endothelin Receptor Antagonist, Placebo control - Coronary Spasm
Phase 2 / Phase 3Enrolling by invitationRadboud University Medical Center1002024-11-112024-11-18

Narrower conditions

Angina Pectoris, Variant (1)

Broader conditions

Angina, Unstable (1)  ·  Cardiovascular Diseases (1)  ·  Chest Pain (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Bosentan (1)  ·  Endothelin Receptor Antagonists (1)

Sponsors

Radboud University Medical Center (1)

Countries

Netherlands (1)

Top investigators

Peter Damman, MD, PhD (1)

Results publications

PMID 40274007